LMAT Stock Recent News

BURLINGTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at 2023 Cantor Global Healthcare Conference on Tuesday, September 26, 2023, at 11:40 AM ET in New York City.

LeMaitre Vascular's sales and profits surged in the second quarter. The company's dividend is supported by earnings.

LeMaitre Vascular's stock offers attractive long-term investment prospects, with recent consolidations offering an entry point for investors. The company reported record quarterly sales in Q2 and is expected to continue unlocking long-term value for shareholders. LMAT's investment in sales team expansion and continued asset growth contribute to its economic profitability and positive sentiment.

Atrion Corp ( ATRI , Financial), a leading player in the Medical Devices & Instruments industry, is currently trading at $557 per share. The company has a market capitalization of $980.596 million and has seen a stock price gain of 4.7% today.

LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Joseph Pellegrino - Chief Financial Officer David Roberts - President Conference Call Participants Brett Fishbin - KeyBanc Capital Markets Inc. Aaron Wukmir - Lake Street Capital Markets Michael Petusky - Barrington Research Associates, Inc. Operator Welcome to the LeMaitre Vascular Q2 2023 Financial Results Conference Call. As a reminder, today's call is being recorded.

LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.29 per share a year ago.

BURLINGTON, Mass., July 31, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences in August.

The iShares Micro-Cap ETF (NYSEARCA: IWC ) is the crème de la crème for finding the top micro-cap stocks to buy. The ETF tracks the performance of the Russell Microcap Index, a collection of the smallest securities in the small-cap Russell 2000 index.

LeMaitre Vascular has the means to keep growing its company faster than the Dow average. The company's dividend should have no problem rising further.

LeMaitre continues to add value for shareholders on multiple fronts. The company's business economics support earnings and dividend growth. Looking ahead, the company could be worth $85 intrinsic value.